Inositol hexaphosphate–loaded red blood cells prevent in vitro sickling

Abstract

Our results indicate that IHP-RBCs prevent in vitro sickling and suggest that it could improve conventional transfusion therapy in terms of transfused volume, frequency, and efficacy.